Skip to main content

Day: May 17, 2021

Logiq Reports Q1 2021 Results; Revenue Up 23% Sequentially to $8.1 Million

THIS PRESS RELEASE IS NOT FOR DISTRIBUTION IN CANADA NEW YORK, May 17, 2021 (GLOBE NEWSWIRE) — Logiq, Inc. (OTCQX: LGIQ), a global provider of award-winning e-commerce and fintech solutions, reported results for the first quarter ended March 31, 2021. The company will hold a conference call at 1:00 p.m. Eastern time today to discuss the results (see dial-in information below).   Q1 2021 Financial HighlightsRevenue for the first quarter increased 23% sequentially to $8.1 million, driven by a $1.1 million increase to a record $5.6 million in revenue by DataLogiq due to strong growth in data monetization, and $328,000 increase in revenue by AppLogiq as a shift to higher margin direct sales gained traction. Consolidated gross profit as a percentage of revenue in the first quarter increased to 27.6%, up 647 basis points sequentially...

Continue reading

MEDIROM Healthcare Technologies Inc., Announces its latest Key Performance Indicators (KPIs)

NEW YORK, May 17, 2021 (GLOBE NEWSWIRE) — MEDIROM Healthcare Technologies Inc. (Nasdaq CM:MRM), a Japanese based holistic healthcare Company (the “Company”), today announced its major Key Performance Indicators, or KPIs, updated for the month of April 2021. The following monthly KPIs provide insight into the business fundamentals and progress of the Company, updated for the month of April 2021.The number of salons was 301 in April 2021, up from 290 in the year-ago period, primarily as a result of openings of new salons. Total customers served were 63,682 in April 2021 versus 13,381 in April 2020, a 376% increase due to a recovery from the COVID-19 impact. Sales per customer slightly decreased to JPY 6,250 in April 2021, up from JPY6,209 in April 2020. The decrease from the previous month is due to promotional pricing for the...

Continue reading

Correction: 9/2021・Trifork publishes Offering Circular and offer price for its intended Initial Public Offering on Nasdaq Copenhagen

Company announcement no. 09 / 2021Schindellegi, Switzerland – 17 May 2021 NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA OR CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION WHERE THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL This announcement does not constitute an offering memorandum or a prospectus as defined by Regulation (EU) No. 2017/1129 of 14 June 2017. The offer to acquire securities pursuant to any offering will be made, and any investor should make his investment decision, solely on the basis of information that is contained in a prospectus to be made generally available in Denmark in connection with the offering. Copies of the prospectus may be obtained by persons in Denmark through the website of the Company as set forth elsewhere in...

Continue reading

Badger Infrastructure Solutions Ltd. May 2021 Cash Dividend

CALGARY, Alberta, May 17, 2021 (GLOBE NEWSWIRE) — Badger Infrastructure Solutions Ltd. (“Badger”) is pleased to announce its May 2021 cash dividend. May 2021 Cash DividendBadger today announced that the directors of Badger declared a cash dividend for the month of May 2021 of $0.0525 per share, which equates to $0.63 per share on an annualized basis. Payment will be made on or about June 15, 2021, to shareholders of record on May 31, 2021. Badger expects that the dividend will be an “eligible dividend” for Canadian income tax purposes and thus qualify for the enhanced gross-up and tax credit regime for certain shareholders. About Badger Infrastructure Solutions Ltd.Badger Infrastructure Solutions Ltd. (TSX:BDGI) is North America’s largest provider of non-destructive excavating services. Badger works for contractors and facility...

Continue reading

PharmaTher Announces FDA Approval of Ketamine IND In The Treatment of Parkinson’s Disease

TORONTO, May 17, 2021 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (CSE: PHRM) (OTCQB: PHRRF), a psychedelics biotech company, is pleased to announce that the U.S. Food and Drug Administration (“FDA”) has approved the Company’s Investigational New Drug (“IND”) application to proceed with a Phase 2 clinical trial to evaluate the safety, efficacy and pharmacokinetics of ketamine in the treatment of levodopa-induced dyskinesia in patients with Parkinson’s disease (“LID-PD”).   PharmaTher expects to begin enrolling patients in the Phase 2 clinical trial in Q3-2021. Assuming the Phase 2 clinical trial is positive, the Company will request a meeting with the FDA to discuss its plan and obtain an agreement to move to a Phase 3 clinical study under the 505(b)(2) regulatory pathway next year. Fabio Chianelli,...

Continue reading

PyroGenesis Announces Q1 2021 Results Revenues $6.3MM; Net Earnings and Comprehensive Income $3.7MM; Gross Margin 34%; Current Backlog $26MM; Basic EPS $0.02

MONTREAL, May 17, 2021 (GLOBE NEWSWIRE) — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (NASDAQ: PYR) (FRA: 8PY), a high-tech company (hereinafter referred to as the “Company” or “PyroGenesis”), that designs, develops, manufactures and commercializes plasma atomized metal powders, environmentally friendly plasma waste-to-energy systems and clean plasma torch products, is pleased to announce today its financial and operational results for the first quarter ended March 31st, 2021. “We are happy to be announcing that our Q1 2021 financial results continue to reflect the historical trend set early last year. The last several quarters saw PyroGenesis more than triple its backlog of signed contracts, reduce debt to basically zero, and recording over $25 million of cash on the balance sheet. All this, while graduating to...

Continue reading

BlackRock® Canada Announces May Cash Distributions for the iShares® ETFs

TORONTO, May 17, 2021 (GLOBE NEWSWIRE) — BlackRock Asset Management Canada Limited (“BlackRock Canada”), an indirect, wholly-owned subsidiary of BlackRock, Inc. (NYSE: BLK), today announced the May 2021 cash distributions for the iShares ETFs listed on the TSX or NEO which pay on a monthly basis as well as XIU. Unitholders of record of a fund on May 25, 2021 will receive cash distributions payable in respect of that fund on May 28, 2021. Details regarding the “per unit” distribution amounts are as follows:Fund Name Fund Ticker Cash Distribution Per Unit ($)iShares 1-10 Year Laddered Corporate Bond Index ETF CBH 0.046iShares 1-5 Year Laddered Corporate Bond Index ETF CBO 0.040iShares S&P/TSX Canadian Dividend Aristocrats Index ETF CDZ 0.085iShares Equal Weight Banc & Lifeco ETF CEW 0.041iShares U.S. High...

Continue reading

Vaccines Market Size 2021 | Is Projected to Reach USD 104.87 Billion by 2027, Exhibiting a CAGR of 10.7 %

Top Players Covered in the Vaccines Market Research Report are GlaxoSmithKline plc., Sanofi, Pfizer Inc., Merck & Co., Inc., Novartis AG, Emergent BioSolutions, Inc., CSL Limited, Inovio Pharmaceuticals, Inc., Bavarian Nordic, Mitsubishi Tanabe Pharma Corporation and other key market players. Pune, India, May 17, 2021 (GLOBE NEWSWIRE) — The global business vaccines market share is projected to reach USD 104.87 billion by 2027, exhibiting a CAGR of 10.7 % during the forecast period due to rise in infectious diseases observes, Fortune Business Insights™ in a published report, titled, “Vaccines Market, 2020-2027.” The increasing prevalence of infectious diseases such as HIV, Hepatitis, and Tuberculosis is making governments and pharmaceutical industries make enormous investments towards vaccine development. For instance, the...

Continue reading

VitalHub Corp. Completes Acquisition of On-Premise Hospital Queue Management Business From Jayex Healthcare Limited

TORONTO, May 17, 2021 (GLOBE NEWSWIRE) — VITALHUB CORP. (TSXV: VHI) (the “Company” or “VitalHub”), is pleased to announce today it has completed the acquisition (the “Acquisition”) of the on-premise hospital queue management business segment (“Jayex System”) of Jayex Healthcare Limited (ASX: JHL) (“Jayex”), a leading UK and Australian e-health provider of integrated SaaS healthcare services delivery platforms. Total consideration paid by VitalHub is £1.3M (the “Purchase Price”). Jayex received the Purchase Price as (i) £1.04M in cash and (ii) £0.26M in VitalHub common shares (the “Shares”). The Shares were issued at CAD$2.915 per Share, and resulted in 150,078 Shares being issued. In addition, for 24 months after closing of the Acquisition, Jayex may receive an earn-out based on earned revenues of the Jayex System, capped at a...

Continue reading

FreightCar America, Inc. Reports First Quarter 2021 Results

First quarter revenues up substantially year-over-year Company raises 2021 delivery outlook Second consecutive quarter of positive gross margins, driven by new operating structure CHICAGO, May 17, 2021 (GLOBE NEWSWIRE) — FreightCar America, Inc. (NASDAQ: RAIL) today reported results for the first quarter ended March 31, 2021. Business Highlights          First quarter revenue of $32.4 million, up 523% year-over-year, on deliveries of 309 railcarsGross margin of $1.8 million, positive for the second consecutive quarter despite the operational complexities of completing the transition from Shoals to CastañosFirst quarter net loss of $38.4 million, or $1.92 per share, which included $6.7 million of restructuring charges and a $22.1 million non-cash charge related to the change in fair market value of warrant liabilityAdjusted...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.